Biotherm, Inc.

Basic Information

5301 Departure Drive
Raleigh, NC, 27604

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Rapid Monitoring of Antithrombin Agents

    Amount: $749,999.00

    A functional assay system for monitoring antithrombin drugs, such as recombinant hirudin andhirudin analogs, in patients will be developed. This assay system will be based on a novel dry reagentparama ...

    SBIR Phase II 1996 Department of Health and Human Services
  2. Rapid Immunoassay for Acute Myocardial Injury Detection

    Amount: $100,000.00

    Phase I is directed at the development of a rapid and quantitative diagnostic immunoassay for acuteinjury. This immunoassay will utilize a proven dry chemistry test system incorporating a cardiac-spec ...

    SBIR Phase I 1995 Department of Health and Human Services
  3. Rapid Monitoring of Antithrombin Agents

    Amount: $75,000.00

    N/A

    SBIR Phase I 1994 Department of Health and Human Services
  4. DRUG CHALLENGE ASSAY FOR USE IN THROMBOLYTIC THERAPY

    Amount: $500,000.00

    A TEST SYSTEM FOR RAPID SCREENING OF PATIENTS PRIOR TO INITIATION OF THROMBOLYTIC THERAPY WILL BE DEVELOPED. THIS SYSTEM WILL BE BASED ON A NOVEL DRY REAGENT ASSAY TECHNOLOGY WHICH RECENTLY HAS BEEN A ...

    SBIR Phase II 1993 Department of Health and Human Services
  5. RAPID FIBRINOGEN ASSAY FOR USE IN THROMBOLYTIC THERAPY

    Amount: $500,000.00

    AN ASSAY SYSTEM FOR MONITORING FUNCTIONAL FIBRINOGEN IN PATIENTS UNDERGOING THROMBOLYTIC THERAPY WILL BE DEVELOPED. THIS SYSTEM WILL BE BASED ON A NOVEL DRY REAGENT ASSAY TECHNOLOGY THAT HAS RECENTLY ...

    SBIR Phase II 1992 Department of Health and Human Services
  6. DRUG CHALLENGE ASSAY FOR USE IN THROMBOLYTIC THERAPY

    Amount: $50,000.00

    N/A

    SBIR Phase I 1991 Department of Health and Human Services
  7. RAPID FIBRINOGEN ASSAY FOR USE IN THROMBOLYTIC THERAPY

    Amount: $50,000.00

    N/A

    SBIR Phase I 1990 Department of Health and Human Services
  8. PORTABLE SYSTEM FOR CONTROL OF ANTICOAGULANT THERAPY

    Amount: $500,000.00

    BIOTHERM, INC. PROPOSES TO DESIGN AND DEVELOP A PORTABLE SYSTEM, ANALOGOUS TO A HAND-HELD GLUCOSE METER, TO PERMIT RAPID, CONVENIENT BLOOD COAGULATION TESTING ON FRESHLY DRAWNSAMPLES FROM PATIENTS UND ...

    SBIR Phase II 1988 Department of Health and Human Services
  9. PORTABLE SYSTEM FOR CONTROL OF ANTICOAGULANT THERAPY

    Amount: $50,000.00

    N/A

    SBIR Phase I 1987 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government